AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TAV HAVALİMANLARI HOLDİNG A.Ş.

Regulatory Filings Dec 23, 2024

5955_rns_2024-12-23_96c431d9-3384-4722-b2ca-7d62d4f3ea82.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

Summary Info CMB approval of the merger of our Company and TAV Gayrimenkul Geliştirme Anonim Şirketi which is 100% owned by our Company
Update Notification Flag Yes
Correction Notification Flag No
Postponed Notification Flag No
Board Decision Date 23.10.2024
Merger Model Merger Through Acquisition
Date Of Financial Statements Base To Merger 30.06.2024
Currency Unit TRY
Acquired Company Trading On The Stock Exchange/Not Trading On The Stock Exchange Share Exchange Rate Group of Share To Be Distributed To Acquired Company Shareholders Form of Share To Be Distributed To Acquired Company Shareholders
TAV Gayrimenkul Geliştirme Anonim Şirketi Not Trading On The Stock Exchange
Share Group Info Paid In Capital Amount Of Capital To Be Increased Due To The Acquisition (TL) Capital To Be Decreased (TL) Target Capital New Shares To Be Given Due To Merger
TAVHL, TRETAVH00018 363.281.250 0 0 363.281.250
Paid In Capital Amount Of Capital To Be Increased Due To The Acquisition (TL) Capital To Be Decreased (TL) Target Capital
TOTAL 363.281.250 TL 0 TL 0 TL 363.281.250 TL
Capital Market Board Application Date Regarding Merger 13.08.2024
Capital Market Board Application Result Regarding Merger APPROVAL
Capital Market Board Approval Date Regarding Merger 20.12.2024
Capital Market Board Application Date 13.08.2024

Additional Explanations

The merger of our wholly-owned subsidiary, TAV Gayrimenkul Geliştirme Anonim Şirketi, through a simplified procedure by acquisition, has been approved by the Capital Markets Board's decision dated 20.12.2024. The announcement text and the merger agreement, both approved by the Board, will be disclosed separately.

Talk to a Data Expert

Have a question? We'll get back to you promptly.